Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Amiodarone in Shockable Cardiac Arrest
NCT06680869Phase 3Recruiting
- Sponsor
- Oregon Health & Science University
- Start
- Jan 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amiodarone in cardiac arrest (SCA), sponsored by Oregon Health & Science University. Started Jan 2025; status: recruiting.
02
Drugs
amiodarone
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT06680869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06680869.